SureTrader SPDR Advertisement
Home > Boards > US Listed > Biotechs > Arena Pharmaceuticals, Inc. (ARNA)

orexigen is no compensation at this point whatsoever period.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
lovethatgreen Member Profile
Member Level 
Followed By 213
Posts 22,984
Boards Moderated 2
Alias Born 08/07/04
160x600 placeholder
Advertisement
Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics "PR Newswire (US)" - 7/24/2015 9:25:00 AM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 7/13/2015 6:38:41 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/9/2015 5:22:52 PM
Obesity Statistics Take a Wrong Turn in This Latest Study "The Motley Fool" - 7/5/2015 2:18:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/16/2015 7:56:18 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/16/2015 7:54:53 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/16/2015 7:53:54 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/16/2015 7:52:47 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/16/2015 7:51:27 PM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 6/16/2015 5:00:28 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/16/2015 4:57:29 PM
Arena Pharmaceuticals Announces the Departure of Chief Financial Officer "PR Newswire (US)" - 6/16/2015 4:30:00 PM
3 Biotech Stocks That I Won't Buy "The Motley Fool" - 6/13/2015 8:04:03 AM
Obesity Drugs: Stocks to Watch "The Motley Fool" - 6/9/2015 11:06:03 AM
Lorcaserin HCl Data to be Presented at American Diabetes Association's 75th Scientific Sessions "PR Newswire (US)" - 6/4/2015 1:30:00 PM
Arena Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference "PR Newswire (US)" - 5/26/2015 8:00:00 AM
Orexigen Therapeutics, Inc. Goes From Biotech Beauty to Dreadful Drugmaker "The Motley Fool" - 5/16/2015 11:04:02 AM
Which of These Growth Stocks Is Most Worthy of Your Money? "The Motley Fool" - 5/16/2015 10:02:02 AM
Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at Upcoming Medical Meetings "PR Newswire (US)" - 5/14/2015 8:00:00 AM
Why Shares of Orexigen Therapeutics, Inc. Cratered Today "The Motley Fool" - 5/13/2015 11:48:02 AM
Orexigen Terminates Required Study for Diet Drug Contrave "Dow Jones News" - 5/12/2015 5:05:54 PM
Why It's Lights Out for Orexigen Therapeutics, Inc. "The Motley Fool" - 5/12/2015 3:24:10 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/11/2015 5:44:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/11/2015 4:22:25 PM
Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2015 Financial Results "PR Newswire (US)" - 5/11/2015 4:07:00 PM
lovethatgreen Member Level  Monday, 05/14/12 08:57:20 AM
Re: gixxer11 post# 4348
Post # of 21963 
orexigen is no compensation at this point whatsoever period.

and vvus at the stage theyre at, is at a disadvantage in several ways

no manufacturing set up....the risks with the drug are numerous combined with detox requirements after 90 days

I could go on

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist